Trial intelligence / Profile preview

Dexmedetomidine vs Ketamine for Shivering Prevention

NCT05718011Phase 4Completed

Sponsor
PAF Hospital Islamabad
Start
Feb 2021
Primary completion
Aug 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of dexmedetomidine in postoperative shivering (2 arms), sponsored by PAF Hospital Islamabad. Primary endpoint: Incidence of Postoperative Shivering. Started Feb 2021; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

postoperative shivering

Beyond the preview

Go deeper on NCT05718011.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05718011.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call